Oppenheimer Assumes Aerie Pharma (AERI) at Outperform
Tweet
Share
E-mailGet Alerts AERI Hot Sheet
Price: $15.25 --0%
Rating Summary:
12 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
12 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Francois Brisebois assumes coverage on Aerie Pharma (NASDAQ: AERI) with a Outperform rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Aerie Pharma click here. For more ratings news on Aerie Pharma click here.
Shares of Aerie Pharma closed at $14.03 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
